Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3043 USD | +5.22% | +8.68% | -1.52% |
Financials (USD)
Sales 2024 * | 5.43M | Sales 2025 * | 33.37M | Capitalization | 29.09M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -7M | EV / Sales 2024 * | 5.36 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.87 x |
P/E ratio 2024 * |
-1.07
x | P/E ratio 2025 * |
-4.82
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Daré Bioscience, Inc.
1 day | +1.12% | ||
1 week | -2.00% | ||
Current month | -41.00% | ||
1 month | -43.84% | ||
3 months | -13.62% | ||
6 months | -32.08% | ||
Current year | -6.41% |
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 75 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.3043 | +5.22% | 107 368 |
24-04-25 | 0.2892 | +1.12% | 325,527 |
24-04-24 | 0.286 | -3.80% | 436,098 |
24-04-23 | 0.2973 | +0.68% | 323,196 |
24-04-22 | 0.2953 | +5.46% | 165,190 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.41% | 29.09M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.85% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- DARE Stock